men are eligible for only 1 in 3 breast cancer clinical trials

In a recent post I discussed the underfunding of basic research on the male form of breast cancer, and advocated for 1% of breast cancer research funding to involve male disease, in proportion to 1% of breast cancer patients being men. So what about clinical trials? When it comes to eligibility for trials it is…

FDA approves Novartis Piqray® - the first and only treatment specifically for patients with a PIK3CA mutation in HR+/HER2- advanced breast cancer

8IGHTWAYS® Prevent Breast Cancer

30+ Organizations That Help Cancer Patients Financially

Disparities in Clinical Research and Cancer Treatment

New Drugs Stir Debate on Rules of Clinical Trials - The New York Times

2024 Cancer Facts & Figures Cancer, 2024--First Year the US Expects More than 2M New Cases of Cancer

Disparities in Clinical Research and Cancer Treatment

NIA-Funded Active Alzheimer's and Related Dementias Clinical Trials and Studies

Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic